胶质纤维酸性蛋白与院前卒中量表在症状发作4.5小时内未选择患者队列中识别卒中及卒中亚型的诊断效能
本研究基于Treat-NASPP项目,纳入299例疑似卒中且症状持续≤4.5小时的患者,前瞻性采集血样并评估NIHSS,回顾性将NIHSS转换为PreSS,用单分子阵列(SIMOA)检测GFAP。结果:颅内出血的交叉验证AUC为0.73(95%CI 0.62-0.84);PreSS与GFAP联合决策树先识别低卒中概率患者,随后GFAP检测颅内出血的敏感性25.0%(95%CI 11.5-43.4)、特异性100.0%(95%CI 98.6-100.0),检测大血管闭塞的敏感性55.6%(95%CI 35.3-74.5)、特异性82.4%(95%CI 77.3-86.7)。结论:在未选择疑似卒中患者中,GFAP单独可识别颅内出血;与PreSS联合决策树可识别卒中模拟病、颅内出血、大血管闭塞及非大血管闭塞性缺血性卒中的高比例亚组。
要点
- 在299例疑似卒中且症状≤4.5小时患者中,GFAP单独识别颅内出血的交叉验证AUC为0.73(95%CI 0.62-0.84)。
- PreSS与GFAP联合决策树中,GFAP检测颅内出血敏感性25.0%(95%CI 11.5-43.4)、特异性100.0%(95%CI 98.6-100.0)。
- 同一决策树检测大血管闭塞敏感性55.6%(95%CI 35.3-74.5)、特异性82.4%(95%CI 77.3-86.7)。
- 决策树首先识别低卒中概率患者,随后依次识别颅内出血和大血管闭塞。
- 队列中44%为急性缺血性卒中、10%为颅内出血、7%为短暂性脑缺血发作、38%为卒中模拟病。
适用人群与场景
- 来自Treat-NASPP项目的疑似卒中且症状持续≤4.5小时的患者,共299例。
- 队列构成:44%急性缺血性卒中、10%颅内出血、7%短暂性脑缺血发作、38%卒中模拟病。
研究设计与关键结果
- 研究类型:基于Treat-NASPP的前瞻性队列子研究,前瞻性采集血样并评估NIHSS,回顾性将NIHSS转换为PreSS,用SIMOA检测GFAP。
- 样本量299例疑似卒中患者,症状持续≤4.5小时。
- 颅内出血的交叉验证AUC为0.73(95%CI 0.62-0.84)。
- PreSS与GFAP联合决策树先识别低卒中概率患者,随后GFAP检测颅内出血敏感性25.0%(95%CI 11.5-43.4)、特异性100.0%(95%CI 98.6-100.0)。
- 决策树检测大血管闭塞敏感性55.6%(95%CI 35.3-74.5)、特异性82.4%(95%CI 77.3-86.7)。
- 结论:在未选择疑似卒中患者中,GFAP单独可识别颅内出血;与PreSS联合决策树可识别卒中模拟病、颅内出血、大血管闭塞及非大血管闭塞性缺血性卒中的高比例亚组。
证据类型、等级与局限
- 证据类型:前瞻性队列子研究(基于Treat-NASPP项目)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 原文未据此给出推荐。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
INTRODUCTION: Rapid identification and treatment of stroke is crucial for the outcome of the patient. We aimed to determine the performance of glial fibrillary acidic protein (GFAP) independently and in combination with the Prehospital Stroke Score (PreSS) for identification and differentiation of acute stroke within 4.5 h after symptom onset.
PATIENTS AND METHODS: Clinical data and serum samples were collected from the Treat-Norwegian Acute Stroke Prehospital Project (Treat-NASPP). Patients with suspected stroke and symptoms lasting ≤ 4.5 h had blood samples collected and were evaluated with the National Institutes of Health Stroke Scale prospectively. In this sub study, NIHSS was retrospectively translated into PreSS and GFAP was measured using the sensitive single molecule array (SIMOA).
RESULTS: A total of 299 patients with suspected stroke were recruited from Treat-NASPP and included in this study (44% acute ischemic stroke (AIS), 10% intracranial hemorrhage (ICrH), 7% transient ischemic attack (TIA), and 38% stroke mimics). ICrH was identified with a cross-fold validated area under the receiver-operating characteristic curve (AUC) of 0.73 (95% CI 0.62-0.84). A decision tree with PreSS and GFAP combined, first identified patients with a low probability of stroke. Subsequently, GFAP detected patients with ICrH with a 25.0% sensitivity (95% CI 11.5-43.4) and 100.0% specificity (95% CI 98.6-100.0). Lastly, patients with large-vessel occlusion (LVO) were detected with a 55.6% sensitivity (95% CI 35.3-74.5) and 82.4% specificity (95% CI 77.3-86.7).
CONCLUSION: In unselected patients with suspected stroke, GFAP alone identified ICrH. Combined in a decision tree, GFAP and PreSS identified subgroups with high proportions of stroke mimics, ICrH, LVO, and AIS (non-LVO strokes).
参考来源
- Jæger HS, Tranberg D, Larsen K, et al. Diagnostic performance of Glial Fibrillary Acidic Protein and Prehospital Stroke Scale for identification of stroke and stroke subtypes in an unselected patient cohort with symptom onset < 4.5 h. Scand J Trauma Resusc Emerg Med. 2023. PMID: 36604741. doi:10.1186/s13049-022-01065-7
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。